Stretch-activated channels in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats

Cell Calcium. 2010 Nov;48(5):251-9. doi: 10.1016/j.ceca.2010.09.011. Epub 2010 Oct 29.

Abstract

Stretch-activated channels (SACs) act as membrane mechanotransducers since they convert physical forces into biological signals and hence into a cell response. Pulmonary arterial smooth muscle cells (PASMCs) are continuously exposed to mechanical stimulations e.g., compression and stretch, that are enhanced under conditions of pulmonary arterial hypertension (PAH). Using the patch-clamp technique (cell-attached configuration) in PASMCs, we showed that applying graded negative pressures (from 0 to -60 mmHg) to the back end of the patch pipette increases occurrence and activity of SACs. The current-voltage relationship (from -80 to +40 mV) was almost linear with a reversal potential of 1 mV and a slope conductance of 34 pS. SACs were inhibited in the presence of GsMTx-4, a specific SACs blocker. Using microspectrofluorimetry (indo-1), we found that hypotonic-induced cell swelling increases intracellular Ca(2+) concentration ([Ca(2+)](i)). This [Ca(2+)](i) increase was markedly inhibited in the absence of external Ca(2+) or in the presence of the following blockers of SACs: gadolinium, streptomycin, and GsMTx-4. Interestingly, in chronically hypoxic rats, an animal model of PAH, SACs were more active and hypotonic-induced calcium response in PASMCs was significantly higher (nearly a two-fold increase). Moreover, unlike in normoxic rats, intrapulmonary artery rings from hypoxic rats mounted in a Mulvany myograph, exhibited a myogenic tone sensitive to SAC blockers. In conclusion, this work demonstrates that SACs in rat PASMCs can be activated by membrane stretch as well as hypotonic stimulation and are responsible for [Ca(2+)](i) increase. The link between SACs activation-induced calcium response and myogenic tone in chronically hypoxic rats suggests that SACs are an important element for the increased pulmonary vascular tone in PAH and that they may represent a molecular target for PAH treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels / metabolism
  • Calcium Channels / physiology*
  • Cells, Cultured
  • Familial Primary Pulmonary Hypertension
  • Gadolinium / pharmacology
  • Hypertension, Pulmonary / metabolism
  • Hypertension, Pulmonary / physiopathology
  • Hypotonic Solutions
  • Hypoxia / metabolism
  • Hypoxia / physiopathology*
  • Intercellular Signaling Peptides and Proteins
  • Male
  • Mechanotransduction, Cellular
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Muscle, Smooth, Vascular / metabolism
  • Muscle, Smooth, Vascular / physiology*
  • Muscle, Smooth, Vascular / physiopathology
  • Myocytes, Smooth Muscle / metabolism
  • Myocytes, Smooth Muscle / physiology*
  • Patch-Clamp Techniques
  • Peptides / pharmacology
  • Pressoreceptors / drug effects
  • Pressoreceptors / metabolism
  • Pressoreceptors / physiology*
  • Pulmonary Artery / metabolism
  • Pulmonary Artery / physiology*
  • Pulmonary Artery / physiopathology
  • Rats
  • Spider Venoms / pharmacology
  • Streptomycin / pharmacology

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Hypotonic Solutions
  • Intercellular Signaling Peptides and Proteins
  • MTx4 protein, Grammostola spatulata
  • Peptides
  • Spider Venoms
  • Gadolinium
  • Calcium
  • Streptomycin